BJDX
What one share of Bluejay Diagnostics holds
Surgical and Medical Instruments and Apparatus
Bluejay Diagnostics, Inc. (“Bluejay”) is a medical diagnostics company focused on improving patient outcomes in critical care settings, with a focus on sepsis. We are working on developing rapid, near-patient tests using whole blood on our Symphony technology platform (“Symphony”), which consists of an analyzer and single-use protein detection cartridges.
Bluejay Diagnostics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$6.65 |
|---|---|
| Cash and investments | $4.84 |
| Book value | $4.75 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | — | −$456.75 | $6.69 | −$177.27 | — | — |
| 2025 | — | −$15.25 | $0.39 | −$13.87 | — | $9.88 |